Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 452089, 8 pages
http://dx.doi.org/10.1155/2014/452089
Research Article

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy

1Department of Medical Oncology and Haematology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of Radiooncology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
3Department of General, Visceral and Transplantation Surgery, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

Received 1 July 2014; Accepted 9 September 2014; Published 20 October 2014

Academic Editor: Tsair-Fwu Lee

Copyright © 2014 M. Sinn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Vincent, J. Herman, R. Schulick, R. H. Hruban, and M. Goggins, “Pancreatic cancer,” The Lancet, vol. 378, no. 9791, pp. 607–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Loehrer Sr., Y. Feng, H. Cardenes et al., “Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial,” Journal of Clinical Oncology, vol. 29, no. 31, pp. 4105–4112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Huguet, N. Girard, C. Séblain-El Guerche, C. Hennequin, F. Mornex, and D. Azria, “Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review,” Journal of Clinical Oncology, vol. 27, no. 13, pp. 2269–2277, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Huguet, K. A. Goodman, D. Azria, S. Racadot, and R. A. Abrams, “Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 5, pp. 1355–1364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. H. Son, J. H. Song, B. O. Choi et al., “The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer,” Radiation Oncology, vol. 7, no. 1, article 203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Huguet, T. André, P. Hammel et al., “Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies,” Journal of Clinical Oncology, vol. 25, no. 3, pp. 326–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Cai, T. S. Hong, S. I. Goldberg et al., “Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010,” Cancer, vol. 119, no. 23, pp. 4196–4204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Reese, W. Lu, and W. F. Regine, “Utilization of intensity-modulated radiation therapy and image-guided radiation therapy in pancreatic cancer: is it beneficial?” Seminars in Radiation Oncology, vol. 24, pp. 132–139, 2014. View at Google Scholar
  9. C. H. Crane, G. R. Varadhachary, J. S. Yordy et al., “Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression,” Journal of Clinical Oncology, vol. 29, no. 22, pp. 3037–3043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-S. Kim, J. H. Lim, J. H. Kim et al., “Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer,” Cancer Chemotherapy and Pharmacology, vol. 70, no. 3, pp. 381–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H.-J. Ch'Ang, Y.-L. Lin, H.-P. Wang et al., “Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. e749–e757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Hammel, F. Huguet, J.-V. Van Laethem et al., “Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study,” Journal of Clinical Oncology, vol. 31, no. 18, 2013, abstract LBA4003. View at Google Scholar
  13. T. Seufferlein, M. Porzner, T. Becker et al., “S3-guideline exocrine pancreatic cancer,” Zeitschrift Für Gastroenterologie, vol. 51, no. 12, pp. 1395–1440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Fietkau, V. Heinemann, H. Oettle, W. T. Knoefel, and A. Tannapfel, “New data on pancreatic cancer,” Onkologie, vol. 33, supplement 4, pp. 31–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Conroy, F. Desseigne, M. Ychou et al., “FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer,” The New England Journal of Medicine, vol. 364, no. 19, pp. 1817–1825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Yachida, S. Jones, I. Bozic et al., “Distant metastasis occurs late during the genetic evolution of pancreatic cancer,” Nature, vol. 467, no. 7319, pp. 1114–1117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Aref and R. Berri, “Role of radiation therapy in the management of locally advanced pancreatic cancer,” Journal of Clinical Oncology, vol. 30, no. 13, pp. 1564–1567, 2012. View at Publisher · View at Google Scholar · View at Scopus